首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Recent results in cancer research

缩写:

ISSN:0080-0015

e-ISSN:2197-6767

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引3477
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mukesh Verma,Sudhir Srivastava Mukesh Verma
Cancer is not a single disease but an accumulation of several events, genetic and epigenetic, arising in a single cell over a long time interval. A high priority in the cancer field is to identify these events. This can be achieved by chara...
Eugene W Gerner,Natalia A Ignatenko,David G Besselsen Eugene W Gerner
Colon cancer is the second leading cause of cancer incidence and death in the USA in 2002. Specific genetic defects have been identified which cause hereditary colon cancers in humans. In addition, a number of intestinal luminal risk factor...
Friedrich Marks,Gerhard Fürstenberger,Gitta Neufang et al. Friedrich Marks et al.
The mouse skin model of multistage carcinogenesis has demonstrated that cancer results from a synergism between genotoxic and nongenotoxic factors. The former induce irreversible genetic alterations, whereas the latter promote tumor develop...
Barry A Gusterson,Wei Cui,A John Clark Barry A Gusterson
We have generated transgenic mice which express the gene encoding Escherichia coli nitroreductase (NTR) specifically in the luminal epithelial cells of the mammary gland and the glial cells of the brain. The enzyme activates an antitumour d...
John P de Koning,Jian-Hua Mao,Allan Balmain John P de Koning
Studies of cancer predisposition have largely concentrated on the role of high-penetrance susceptibility genes. Less than 10% of the total human tumor burden, however, is accounted for by mutations in these genes. More genetic variation in ...
Paul D P Pharoah Paul D P Pharoah
A polygenic approach to disease prevention has become a realistic goal that has arisen from the sequencing of the human genome. Some believe it will be possible to identify individuals as susceptible by their genotype and to prevent disease...
Viktor Meineke,Carolina Pfaffendorf,Michaela Schinn et al. Viktor Meineke et al.
Possible effects of 1,25-dihydoxyvitamin D3 (vitamin D) on ionizing radiation-induced cell damage have been unknown until now. The task of the present study was to analyze, in a human keratinocyte cell line (HaCaT), the effects of a preincu...
Heide S Cross,Enikö Kállay,Hesso Farhan et al. Heide S Cross et al.
Though 1,25-dihydroxyvitamin D3 (1,25-D3) as well as some vitamin D analogs have an antimitotic as well as a differentiating action, therapeutic application in tumor patients is still precluded due to their hypercalcemic action at the neces...
Erum A Hussain,Rajeshwari R Mehta,Rahul Ray et al. Erum A Hussain et al.
It is now well established that the active metabolite of vitamin D3, 1alpha,25(OH)2D3, regulates cell growth and differentiation in various in vitro cancer models. However, its clinical use is precluded due to its hypercalcemic activity in ...
Daniel Lechner,Heide S Cross Daniel Lechner
1alpha,25(OH)2D3 is a potent growth inhibitor of different cancer cell lines. The steroid hormone is not only synthesized in the kidney, but also at extrarenal sites. Unfortunately, this potential autocrine/paracrine defense mechanism is lo...